These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31189726)

  • 1. Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation.
    Halpern J; Paolo D; Huang A
    J Med Ethics; 2019 Jun; 45(6):384-387. PubMed ID: 31189726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WMP; Weinstein ND; Mori M; Degnin C; Sulmasy DP
    J Empir Res Hum Res Ethics; 2017 Oct; 12(4):280-288. PubMed ID: 28728498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrealistic optimism and the ethics of phase I cancer research.
    Crites J; Kodish E
    J Med Ethics; 2013 Jun; 39(6):403-6. PubMed ID: 23118468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed Consent, Therapeutic Misconception, and Unrealistic Optimism.
    Jansen LA
    Perspect Biol Med; 2020; 63(2):359-373. PubMed ID: 33416658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.
    Horng S; Grady C
    IRB; 2003; 25(1):11-6. PubMed ID: 12833900
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase 1 oncology trials and informed consent.
    Miller FG; Joffe S
    J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispositional optimism and therapeutic expectations in early-phase oncology trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WM; Weinstein ND; Mori M; Daffé R; Sulmasy DP
    Cancer; 2016 Apr; 122(8):1238-46. PubMed ID: 26882017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of control and unrealistic optimism in early-phase cancer trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WMP; Weinstein ND; Mori M; Degnin C; Sulmasy DP
    J Med Ethics; 2018 Feb; 44(2):121-127. PubMed ID: 28774957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Misperceptions in Early-Phase Cancer Trials: From Categorical to Continuous.
    Sisk BA; Kodish E
    IRB; 2018; 40(4):13-20. PubMed ID: 30387976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic misconception in early phase gene transfer trials.
    Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK
    Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis.
    Kimmelman J; Palmour N
    J Med Ethics; 2005 Apr; 31(4):209-14. PubMed ID: 15800361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential subjects' responses to an ethics questionnaire in a phase I study of deep brain stimulation in early Parkinson's disease.
    Finder SG; Bliton MJ; Gill CE; Davis TL; Konrad PE; Charles PD
    J Clin Ethics; 2012; 23(3):207-16. PubMed ID: 23256400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking Respect Seriously: Clinical Research and the Demands of Informed Consent.
    Jansen LA
    J Med Philos; 2018 May; 43(3):342-360. PubMed ID: 29746686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed consent to HIV cure research.
    Bromwich D; Millum JR
    J Med Ethics; 2017 Feb; 43(2):108-113. PubMed ID: 27288096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials.
    Reeder-Hayes KE; Roberts MC; Henderson GE; Dees EC
    J Oncol Pract; 2017 Oct; 13(10):e863-e873. PubMed ID: 28837373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials.
    Behrendt C; Gölz T; Roesler C; Bertz H; Wünsch A
    J Med Ethics; 2011 Feb; 37(2):74-80. PubMed ID: 21098797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The problem with optimism in clinical trials.
    Jansen LA
    IRB; 2006; 28(4):13-9. PubMed ID: 17036434
    [No Abstract]   [Full Text] [Related]  

  • 19. Two concepts of therapeutic optimism.
    Jansen LA
    J Med Ethics; 2011 Sep; 37(9):563-6. PubMed ID: 21551464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.